银屑病成人患者睡眠障碍的患病率及相关因素
这项横断面研究纳入334例银屑病患者和126名对照,发现59%患者与34%对照存在睡眠障碍(PSQI>5,P<0.001),患者睡眠时间较对照少1小时(中位数6 vs 7小时,P<0.001)。焦虑和抑郁是睡眠受损最强的预测因素,并分别介导瘙痒强度与睡眠障碍关联的42%和37%。
要点
- 银屑病患者睡眠障碍患病率为59%,显著高于对照的34%(P<0.001)。
- 患者睡眠时间较对照少1小时(中位数6 vs 7小时,P<0.001)。
- 焦虑和抑郁是睡眠受损最强预测因素,分别介导瘙痒与睡眠关联的42%和37%。
核心结论
- 银屑病患者睡眠障碍患病率很高,应对患者评估睡眠受损、瘙痒、焦虑和抑郁。
- 作者认为减少瘙痒应被视为重要治疗目标,同时配合减轻焦虑和抑郁的治疗。
研究设计与样本
- 横断面研究,纳入334例银屑病患者(应答率86%)和126名对照(应答率82%)。
- 评估工具包括匹兹堡睡眠质量指数(PSQI)、银屑病严重程度、瘙痒特征(含平均瘙痒强度视觉模拟量表VAS)、共病严重程度、焦虑和抑郁(医院焦虑抑郁量表HADS)及生活质量(皮肤病生活质量指数DLQI和短表12 SF12)。
主要发现
- 59%患者和34%对照存在睡眠障碍(PSQI>5),差异有统计学意义(P<0.001)。
- 患者睡眠时间较对照少1小时(中位数6 vs 7小时,P<0.001)。
- 无瘙痒患者整体PSQI睡眠受损程度轻于强瘙痒患者(P<0.001)和极强瘙痒患者(P<0.001)。
- 焦虑(HADS-A)和抑郁(HADS-D)水平是睡眠受损最强预测因素,其后依次为夜间瘙痒加重、年龄、女性、晨间瘙痒加重、平均瘙痒强度(VAS)、确诊抑郁和胃食管反流病,合计解释整体睡眠质量变异的32%-37%。
- 焦虑(HADS-A)和抑郁(HADS-D)均为显著中介变量,分别解释瘙痒强度(VAS)与睡眠受损关联的42%和37%。
临床怎么用
- 作者认为应对银屑病患者评估睡眠受损、瘙痒、焦虑和抑郁。
- 作者认为减少瘙痒应被视为重要治疗目标,同时配合减轻焦虑和抑郁的治疗。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Sleep, which is crucial for restoring of physiological functions and health, is reportedly impaired in psoriasis. The role of different potential sleep confounding factors, including detailed pruritus characteristics, and the complex interplay between psychological variables (anxiety and depression), pruritus and sleep disturbance in psoriasis remain insufficiently investigated. OBJECTIVES: To investigate sleep characteristics and to identify clinical, demographic and psychological factors associated with sleep disturbance in psoriasis. METHODS: This cross-sectional study included 334 psoriasis patients (response rate 86%) and 126 control subjects (response rate 82%). Measures included sleep quality [Pittsburgh Sleep Quality Index (PSQI)], psoriasis severity, pruritus characteristics, including average pruritus intensity [visual analogue scale (VAS)], severity of comorbidities, anxiety and depression (Hospital Anxiety and Depression Scale - HADS) and quality of life (Dermatology Life Quality Index - DLQI, and Short Form 12 - SF12). RESULTS: Fifty-nine per cent of patients and 34% of control subjects (P < 0.001) suffered from sleep disturbance (PSQI > 5). Patients slept 1 h less than control subjects (median 6 vs. 7 h, P < 0.001). Patients without pruritus had less impaired sleep (global PSQI) than patients with strong (P < 0.001) and very strong pruritus (P < 0.001). Anxiety (HADS-A) and depression (HADS-D) levels were the strongest predictors of sleep impairment, followed by pruritus exacerbation at night, age, female sex, pruritus exacerbation in the morning, average pruritus intensity (VAS), diagnosed depression and gastroesophageal reflux disease, altogether explaining 32%-37% of the variance in global sleep quality. Both anxiety (HADS-A) and depression (HADS-D) were significant mediators explaining the association between pruritus intensity (VAS) and sleep impairment in 42% and 37% respectively. CONCLUSIONS: Sleep disturbance in patients with psoriasis is highly prevalent. Patients with psoriasis should be assessed for sleep impairment, pruritus, anxiety and depression. Reduction in pruritus should be considered as an important therapeutic goal, along with therapies aimed at reducing anxiety and depression.
引用
- Sahin E, Hawro M, Weller K, et al. Prevalence and factors associated with sleep disturbance in adult patients with psoriasis. J Eur Acad Dermatol Venereol. 2022. PMID: 35020226. doi:10.1111/jdv.17917
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。